JESSICA ROBERTS: Open Payments
NPI 1174080071 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 9 payments from 7 companies in 2025. Trend: 2023 $65 · 2024 $77 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Eisai Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Impel Pharmaceuticals LLC | 1 | $17 |
Products named: HYQVIA, AUSTEDO XR, AMYVID, KESIMPTA, Leqembi, INGREZZA, TRUDHESA.
Industry payments across OH — which companies pay providers there.
